In American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), and Chinese Diabetes Society (CDS) guidelines, both insulin and GLP-1 RA could be the initial option when oral therapies fail to provide adequate glycemic control, and nearly 70 % Chinese patients choose premixed insulin as the initial insulin therapy [4]. This evidence concerns the gene GCG and diabetes mellitus.